Analyze the ingredients and pharmacological effects of Bituvi/Bikonprenol Tablets

Biktarvy is a broad-spectrum three-in-one compound preparation against HIV-1 (AIDS). The combination contains three active ingredients: bictegravir sodium (bictegravir), emtricitabine and tenofovir fumarate. alafenamide, TAF). This fixed-dose combination is designed to be taken orally once a day and can form a complete treatment plan without the need for other antiviral drugs. It is known for its high efficiency, convenience and good tolerability in clinical use.

Bictegravir sodium is the core component and belongs to the integrase strand transfer inhibitor (INSTI) class. It blocks the HIV virus from integrating its genetic material into the host cell DNA, thereby interrupting its ability to replicate in the early stages of the virus's life cycle. Compared with early integrase inhibitors, BIC has a higher resistance barrier, which means that it is more difficult for the virus to become resistant to it through mutation. This is a very important advantage in current HIV treatment.

Emtricitabine (FTC) and tenofovir alafenamide (TAF) are nucleoside reverse transcriptase inhibitors (NRTIs). Their mechanism is to interfere with the reverse transcription process required for viral replication, thereby preventing viral RNA from being reversed into DNA. The two components work synergistically in preventing viral amplification. As an upgraded version of tenofovir, TAF has better tissue penetration than the early tenofovir disoproxil (TDF) and can work at a lower dose with the same efficacy, thus significantly reducing potential adverse effects on the kidneys and bone density.

This triple drug combination strategy enables Bikeren Prenol Tablets to have a "whole-process blocking" mechanism in anti-HIV treatment, that is, to intervene in all key aspects of virus invasion, integration, and replication of host cells. Thanks to its single-piece formulation and once-daily usage design, it not only improves patient compliance but also simplifies the management of long-term antiviral therapy. In addition, Bikeren Prenol Tablets are active against multiple HIV subtypes and are suitable for first-time treatment patients. They can also be used as a drug change program for some patients who have failed previous treatments.

Reference materials:https://www.biktarvy.com/